COMBI — Combigene AB Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapSucker Stock
- SEK142.96m
- SEK22.46m
- SEK26.70m
Annual cashflow statement for Combigene AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | Interim Report | ARS | ARS |
| Standards: | SAS | SAS | — | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.2 | -17.7 | — | 21 | -6.95 |
| Amortisation | |||||
| Non-Cash Items | — | 1.17 | — | — | -11.7 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 13.4 | -5.08 | -38.3 | -1.44 | -0.614 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.228 | -21.6 | -38.3 | 22.1 | -16.7 |
| Capital Expenditures | -0.43 | 0 | — | -0.148 | 0 |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -1.52 | -0.104 | 0 | — |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.43 | -1.52 | -0.104 | -0.148 | 0 |
| Financing Cash Flow Items | — | -0.12 | 72.2 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 27.1 | 6.49 | 72.2 | 65.9 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 26.9 | -16.6 | 33.7 | 87.8 | -4.97 |